Concepedia

Toby Passioura

TP

30

Publications

1.3K

Citations

20

H-Index

2004

Active since

Affiliations

The University of Tokyo(Current)

The University of Sydney

Australian Research Council

Johnson & Johnson (Australia)

Children's Cancer Institute Australia

Toby Passioura is an author at The University of Tokyo specializing in medicine, cell biology, and drug discovery.

ORCID

Top concepts

Publications per year

2004–2023

30

Publications

30

Highly selective inhibition of histone demethylases by de novo macrocyclic peptides

Akane Kawamura, Martin Münzel, Tatsuya Kojima et al. · Nature Communications · 2017 · 146 citations · Full text

Nonproteinogenic deep mutational scanning of linear and cyclic peptides

Joseph M. Rogers, Toby Passioura, Hiroaki Suga · Proceedings of the National Academy of Sciences · 2018 · 88 citations · Full text

Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display

Alexander Norman, Charlotte Franck, Mary Christie et al. · ACS Central Science · 2021 · 76 citations · Full text

<i>De Novo</i> Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease

Christoph Nitsche, Toby Passioura, Paul Varava et al. · ACS Medicinal Chemistry Letters · 2019 · 72 citations · Full text

Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor

Katsuya Sakai, Toby Passioura, Hiroki Sato et al. · Nature Chemical Biology · 2019 · 72 citations

, , +9

Rows per page

1–5 of 30